Search hospitals > Kentucky > Lexington
Albert B. Chandler Medical Center, University of Kentucky
Claim this profileLexington, Kentucky 40508
Global Leader in Lung Cancer
Global Leader in Ovarian Cancer
Conducts research for Leukemia
Conducts research for Head and Neck Cancers
Conducts research for Lymphoma
241 reported clinical trials
7 medical researchers
Summary
Albert B. Chandler Medical Center, University of Kentucky is a medical facility located in Lexington, Kentucky. This center is recognized for care of Lung Cancer, Ovarian Cancer, Leukemia, Head and Neck Cancers, Lymphoma and other specialties. Albert B. Chandler Medical Center, University of Kentucky is involved with conducting 241 clinical trials across 209 conditions. There are 7 research doctors associated with this hospital, such as Daniel Lee, MD, Francis Farhadi, MD, PhD, Sharoon Qaiser, and Frederick R. Ueland.Area of expertise
1Lung Cancer
Global LeaderStage I
Stage II
Stage III
2Ovarian Cancer
Global LeaderStage III
Stage IV
BRCA
Top PIs
Daniel Lee, MDWills Eye Hospital2 years of reported clinical research
Studies Glaucoma
Studies Open-Angle Glaucoma
10 reported clinical trials
18 drugs studied
Francis Farhadi, MD, PhDUniversity of Kentucky1 year of reported clinical research
Studies Wounds and Injuries
Studies Spinal Cord Injury
6 reported clinical trials
9 drugs studied
Sharoon QaiserUniversity of Kentucky Chandler Medical Center4 years of reported clinical research
Studies Migraine
4 reported clinical trials
3 drugs studied
Frederick R. UelandUniversity of Kentucky/Markey Cancer Center6 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
3 reported clinical trials
9 drugs studied
Clinical Trials running at Albert B. Chandler Medical Center, University of Kentucky
Migraine
Prostate Cancer
Spinal Cord Injury
Wounds and Injuries
Crohn's Disease
Hodgkin's Lymphoma
Hepatitis C
Cancer
Alzheimer's Disease
Lymphoma
Lasmiditan
for Pediatric Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Recruiting2 awards Phase 3
Galcanezumab
for Migraine
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Recruiting1 award Phase 31 criteria
Ubrogepant
for Pediatric Migraine
This trial will test if ubrogepant is safe and effective for young people with migraines. Ubrogepant is a medication taken by mouth to treat migraine headaches. It works by blocking a protein in the brain that causes migraine pain. The study focuses on children and adolescents who suffer from migraines.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Albert B. Chandler Medical Center, University of Kentucky?
Albert B. Chandler Medical Center, University of Kentucky is a medical facility located in Lexington, Kentucky. This center is recognized for care of Lung Cancer, Ovarian Cancer, Leukemia, Head and Neck Cancers, Lymphoma and other specialties. Albert B. Chandler Medical Center, University of Kentucky is involved with conducting 241 clinical trials across 209 conditions. There are 7 research doctors associated with this hospital, such as Daniel Lee, MD, Francis Farhadi, MD, PhD, Sharoon Qaiser, and Frederick R. Ueland.